Announcements Trials

Browse Landscape

Status

Completed 5 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Melanoma 2 Uterine Cervical Neoplasms 1 Solid Tumor, Adult 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuromyelitis Optica 1 Neoplasms, Second Primary 1 Neoplasm Metastasis 1 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 1 Myasthenia Gravis 1 Multiple Sclerosis 1 Lung Neoplasms 1 Laryngectomy; Status 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Endometrial Neoplasms 1 Encephalomyelitis, Acute Disseminated 1 Carcinoma, Renal Cell 1 COVID-19 1 Breast Neoplasms 1 Autoimmune Diseases of the Nervous System 1

Interventions

Cisplatin 43 Radiotherapy 20 Paclitaxel 20 Brachytherapy 19 Carboplatin 17 Drug Therapy 6 Bevacizumab 6 camrelizumab 5 toripalimab 4 nimotuzumab 4 Radiation 4 Neoadjuvant Therapy 4 Gemcitabine 4 tislelizumab 3 sintilimab 3 pembrolizumab 3 apatinib 3 Vaccines 3 TP protocol 3 Surgical Procedures, Operative 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 nedaplatin 2 fludarabine 2 endostar protein 2 anlotinib 2 Topotecan 2 Surveys and Questionnaires 2 Sentinel Lymph Node Biopsy 2 Radiotherapy, Intensity-Modulated 2 Mindfulness 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Uterine Cervical Neoplasms × Data Collection × Clear all

NCT06208319 2024-02-01

IACOL

Assistance Publique - Hôpitaux de Paris

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡